How biopharma companies can make the best choices

Home / Media Center / Trinity in the News / How biopharma companies can make the best choices

The Pharma Letter  |  September 20, 2024

The biopharma industry is intensely competitive, and companies must go to great lengths to gain any commercial edge. However, it is also an industry that sees more failure than success. Leslie Orne, President & CEO of Trinity Life Sciences, provides an expert view in The Pharma Letter on how biopharma companies can make the best choices to achieve commercial success.